EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin

Yurie Tokito, Kazunaga Ishigaki, Katsuhiko Nara, Go Endo, Hiroto Nishio, Koshiro Fukuda, Tatsunori Suzuki, Yasuyoshi Sato, Naminatsu Takahara, Narikazu Boku, Mitsuhiro Fujishiro

Supportive Care in Cancer · 2026-06 · 34 (6)

DOI: 10.1007/s00520-026-10845-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 03.06.2026. Verfasst von Yurie Tokito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-Ku, Tokyo, 113-8655, Japan. Hauptthemen laut MEDLINE: Antiemetics, Pancreatic Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Vomiting. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The University of Tokyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntiemeticsPancreatic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsVomitingNauseaHumansFluorouracilFemaleRetrospective StudiesLeucovorinMaleIrinotecanAgedDexamethasoneMiddle AgedSerotonin 5-HT3 Receptor Antagonists

Stichwörter der Autor:innen

Advanced pancreatic cancerChemotherapy-induced nausea and vomitingSteroid-omitting antiemetic therapy

Substanzen

AntiemeticsFluorouracilLeucovorinIrinotecanDexamethasoneSerotonin 5-HT3 Receptor Antagonists

Autor:innen und Institutionen

  • Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-Ku, Tokyo, 113-8655, Japan.
  • Department of Clinical Oncology, The University of Tokyo Hospital, Tokyo, Japan.
  • Department of Pharmaceutical Department, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-Ku, Tokyo, 113-8655, Japan. naminatsu.takahara@gmail.com.
  • Department of Oncology and General Medicine, Institute of Medical Science, IMSUT Hospital, University of Tokyo, Tokyo, Japan.

Förderung

  • The University of Tokyo

Zitieren

APA

Tokito, Y., Ishigaki, K., Nara, K., Endo, G., Nishio, H., Fukuda, K., Suzuki, T., Sato, Y., Takahara, N., Boku, N., & Fujishiro, M. (2026). Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin. Supportive Care in Cancer, 34(6). https://doi.org/10.1007/s00520-026-10845-1

Vancouver

Tokito Y, Ishigaki K, Nara K, Endo G, Nishio H, Fukuda K, et al. Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin. Supportive Care in Cancer. 2026;34(6). doi:10.1007/s00520-026-10845-1

BibTeX
@article{Tokito2026,
  author = {Tokito, Yurie and Ishigaki, Kazunaga and Nara, Katsuhiko and Endo, Go and Nishio, Hiroto and Fukuda, Koshiro and Suzuki, Tatsunori and Sato, Yasuyoshi and Takahara, Naminatsu and Boku, Narikazu and Fujishiro, Mitsuhiro},
  title = {Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {6},
  doi = {10.1007/s00520-026-10845-1}
}
Kostenlos starten →